Cargando…
1639. Efficacy of Voriconazole Prophylaxis Followed by Therapeutic Liposomal Amphotericin B for the Treatment of Murine Pulmonary Aspergillosis Caused by Azole-Resistant Aspergillus fumigatus Strains
BACKGROUND: Antifungal treatment for pulmonary aspergillosis is more difficult if the fungal strain causing the infection is azole resistant. To investigate this problem, we used a murine model of pulmonary aspergillosis caused by azole-resistant Aspergillus fumigatus strains V29 and V45, and compar...
Autores principales: | Olson, Jon, Slarve, Matthew, Adler-Moore, Jill |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6252533/ http://dx.doi.org/10.1093/ofid/ofy209.109 |
Ejemplares similares
-
1577. Particle Characterization of Nebulized Liposomal Amphotericin B and Its Use in the Treatment of Murine Pulmonary Aspergillosis
por: Dave, Janam J, et al.
Publicado: (2019) -
Azole Resistance of Aspergillus fumigatus in Immunocompromised Patients with Invasive Aspergillosis
por: van der Linden, Jan W.M., et al.
Publicado: (2016) -
Azole Resistance of Aspergillus fumigatus in Immunocompromised Patients with Invasive Aspergillosis
por: Alanio, Alexandre, et al.
Publicado: (2016) -
Effect of amphotericin B and voriconazole on the outgrowth of conidia of Aspergillus fumigatus followed by time-lapse microscopy
por: Talas, Laszlo, et al.
Publicado: (2019) -
Itraconazole, Voriconazole, and Posaconazole CLSI MIC Distributions for Wild-Type and Azole-Resistant Aspergillus fumigatus Isolates
por: Buil, Jochem B., et al.
Publicado: (2018)